Nasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
CNN on MSN13d
NIH interim director comes from its research ranks but is known for questioning Covid-19 vaccine mandates
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
La Crosse Tribune7d
Development of an mRNA vaccine for Covid-19 was fast
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
The Hill on MSN10d
Trump to reinstate military members dismissed over COVID-19 shot refusal
Service members dismissed from the military for failing to get vaccinated against COVID-19 will be reinstated with full back ...
thecardiologyadvisor.com3d
COVID-19 Vaccine Confers Protection Against Post-COVID-19 Conditions
The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.
EurekAlert!2d
Nasal COVID-19 vaccine based on WashU technology to enter US clinical trials
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...